An article appears and the next day the share price jumps 37%. Was this article widely reported in the general media? NO. Who might be in the best position to take advantage of this news? People who read AJIC, i.e. infectious disease specialists, that's who. I bet we have a lot of new shareholders today and I bet most of them are docs who understand the significance of what they read in their latest issue of AJIC.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.